Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R Brunner

Showing results (561-570 of 564) with videos related to

Pageof 57
Sort By:
You have reached the last page of results.This site can display upto 564 results.
The American Journal of the Medical Sciences|January 1, 1990
Renal and hemodynamic effects of atrial natriuretic peptide in patients with cirrhosisT Fried, G R Aronoff, J E Benabe, et al.
Clinical Pharmacology and Therapeutics|January 1, 1997
DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartanM R Goldberg, M W Lo, D D Christ, et al.
Clinical Pharmacology and Therapeutics|May 1, 1981
Three new long-acting converting-enzyme inhibitors: relationship between plasma converting-enzyme activity and response to angiotensin IJ Biollaz, M Burnier, G A Turini, et al.
Archives of Gynecology and Obstetrics|October 4, 2016
H Bösiger, D Surbek, N Pavic, et al.
Pageof 57

Showing results (561-570 of 564) with videos related to

Sort By:
Pageof 57
You have reached the last page of results.This site can display upto 564 results.
The American Journal of the Medical Sciences|January 1, 1990
Renal and hemodynamic effects of atrial natriuretic peptide in patients with cirrhosisT Fried, G R Aronoff, J E Benabe, et al.
Clinical Pharmacology and Therapeutics|January 1, 1997
DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartanM R Goldberg, M W Lo, D D Christ, et al.
Clinical Pharmacology and Therapeutics|May 1, 1981
Three new long-acting converting-enzyme inhibitors: relationship between plasma converting-enzyme activity and response to angiotensin IJ Biollaz, M Burnier, G A Turini, et al.
Archives of Gynecology and Obstetrics|October 4, 2016
H Bösiger, D Surbek, N Pavic, et al.
Pageof 57